Antonio Migliarese - Jan 3, 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CFO
Signature
/s/ Antonio Migliarese
Stock symbol
CYDY
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 09:04 PM
Previous filing
Nov 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -50K -100% 0 Jan 3, 2024 Common Stock 50K $1.03 Direct F1, F2
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -50K -100% 0 Jan 3, 2024 Common Stock 50K $1.10 Direct F1, F2
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -100K -100% 0 Jan 3, 2024 Common Stock 100K $5.57 Direct F1, F2
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -50K -100% 0 Jan 3, 2024 Common Stock 50K $5.54 Direct F2, F3
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -1M -100% 0 Jan 3, 2024 Common Stock 1M $1.32 Direct F2, F4
transaction CYDY Non-qualified stock option (right to buy) Disposed to Issuer -630K -100% 0 Jan 3, 2024 Common Stock 630K $0.58 Direct F2, F5
transaction CYDY Non-qualified stock option (right to buy) Award +50K 50K Jan 3, 2024 Common Stock 50K $0.21 Direct F2
transaction CYDY Non-qualified stock option (right to buy) Award +50K 50K Jan 3, 2024 Common Stock 50K $0.21 Direct F2
transaction CYDY Non-qualified stock option (right to buy) Award +100K 100K Jan 3, 2024 Common Stock 100K $0.21 Direct F2
transaction CYDY Non-qualified stock option (right to buy) Award +50K 50K Jan 3, 2024 Common Stock 50K $0.21 Direct F2, F6
transaction CYDY Non-qualified stock option (right to buy) Award +1M 1M Jan 3, 2024 Common Stock 1M $0.21 Direct F2, F7
transaction CYDY Non-qualified stock option (right to buy) Award +630K 630K Jan 3, 2024 Common Stock 630K $0.21 Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was fully vested and exercisable prior to January 3, 2024.
F2 The outstanding option was cancelled in exchange for a new option having a lower exercise price.
F3 Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022.
F4 Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022.
F5 25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
F6 33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024.
F7 666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024.
F8 301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026.